While TCGA has provided invaluable insights, it has certain limitations. For instance, it primarily focuses on primary tumors, with less emphasis on metastatic cancers. Additionally, the majority of samples are from adult patients, meaning that pediatric cancers are underrepresented. Moreover, the data predominantly comes from patients in the United States, which may limit the generalizability of findings to other populations.
